BRPI0615958B8 - composição para aumentar a permeabilidade de paredes celulares e membranas celulares de mycobacterium sp. e método para detectar um alvo em uma célula - Google Patents
composição para aumentar a permeabilidade de paredes celulares e membranas celulares de mycobacterium sp. e método para detectar um alvo em uma célulaInfo
- Publication number
- BRPI0615958B8 BRPI0615958B8 BRPI0615958A BRPI0615958A BRPI0615958B8 BR PI0615958 B8 BRPI0615958 B8 BR PI0615958B8 BR PI0615958 A BRPI0615958 A BR PI0615958A BR PI0615958 A BRPI0615958 A BR PI0615958A BR PI0615958 B8 BRPI0615958 B8 BR PI0615958B8
- Authority
- BR
- Brazil
- Prior art keywords
- cell
- target
- pathogen
- mycobacterium
- permeability
- Prior art date
Links
- 210000004027 cell Anatomy 0.000 title abstract 5
- 210000000170 cell membrane Anatomy 0.000 title abstract 2
- 210000002421 cell wall Anatomy 0.000 title abstract 2
- 241000187488 Mycobacterium sp. Species 0.000 title 1
- 230000035699 permeability Effects 0.000 title 1
- 244000052769 pathogen Species 0.000 abstract 3
- 230000001717 pathogenic effect Effects 0.000 abstract 3
- 108091093037 Peptide nucleic acid Proteins 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- 229930186217 Glycolipid Natural products 0.000 abstract 1
- 108010015899 Glycopeptides Proteins 0.000 abstract 1
- 102000002068 Glycopeptides Human genes 0.000 abstract 1
- 108010028921 Lipopeptides Proteins 0.000 abstract 1
- 102000029797 Prion Human genes 0.000 abstract 1
- 108091000054 Prion Proteins 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 210000003850 cellular structure Anatomy 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 210000000633 nuclear envelope Anatomy 0.000 abstract 1
- 210000003463 organelle Anatomy 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6841—In situ hybridisation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
- G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
Abstract
composição para aumentar a permeabilidade de paredes celulares, membranas celulares e membranas nucleares e método para detectar um alvo em uma célula. a presente invenção provê um método para permitir que partículas externas penetrem, mais eficientemente, à parede celular, membrana celular, membrana de organelas e/ou membrana nuclear de uma célula e que hibridize ou se ligue a um alvo complementar na célula. as células podem ser de uma cultura ou a partir de uma espécie obtida a partir de um paciente. a partícula externa pode ser uma sonda consistindo de, por exemplo, tanto individualmente quanto em qualquer combinação de dois ou mais de: dna, rna, ácidos nucléicos de peptídeos (pna), glicopeptídeos, lipopeptídeos, glicolipidios e prions. o alvo é uma célula, um componente celular ou, preferivelmente, um patógeno ou componente de patógeno. o patógeno pode ser, por exemplo, bactéria, fungo, levedura ou vírus.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70332905P | 2005-07-28 | 2005-07-28 | |
US60/703,329 | 2005-07-28 | ||
PCT/US2006/029501 WO2007016379A2 (en) | 2005-07-28 | 2006-07-27 | Method for improving cell permeability to foreign particles |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0615958A2 BRPI0615958A2 (pt) | 2011-05-31 |
BRPI0615958B1 BRPI0615958B1 (pt) | 2020-11-10 |
BRPI0615958B8 true BRPI0615958B8 (pt) | 2021-05-25 |
Family
ID=37709226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0615958A BRPI0615958B8 (pt) | 2005-07-28 | 2006-07-27 | composição para aumentar a permeabilidade de paredes celulares e membranas celulares de mycobacterium sp. e método para detectar um alvo em uma célula |
Country Status (16)
Country | Link |
---|---|
US (1) | US8632963B2 (pt) |
EP (1) | EP1924252B1 (pt) |
JP (1) | JP5132557B2 (pt) |
CN (1) | CN101272773A (pt) |
AT (1) | ATE523193T1 (pt) |
AU (1) | AU2006275632B2 (pt) |
BR (1) | BRPI0615958B8 (pt) |
CA (1) | CA2641599C (pt) |
CY (1) | CY1111959T1 (pt) |
DK (1) | DK1924252T3 (pt) |
ES (1) | ES2372538T3 (pt) |
PL (1) | PL1924252T3 (pt) |
PT (1) | PT1924252E (pt) |
SI (1) | SI1924252T1 (pt) |
WO (1) | WO2007016379A2 (pt) |
ZA (1) | ZA200801859B (pt) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8758990B2 (en) * | 2005-07-28 | 2014-06-24 | Id-Fish Technology, Inc. | Methods for detecting and differentiating Mycobacterium genus and Mycobacterium avium complex in a sample or culture |
US9481912B2 (en) | 2006-09-12 | 2016-11-01 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and identifying nucleic acid sequences in biological samples |
BRPI0717707B8 (pt) | 2006-11-30 | 2021-07-27 | Id Fish Tech Inc | método para detectar a presença de plasmodium em uma amostra, fragmento de ácido nucléico e método para detectar e diferenciar espécies de protozoários |
US8323901B2 (en) * | 2006-11-30 | 2012-12-04 | Id-Fish Technology, Inc. | Nucleic acid probes and methods for detecting plasmodium parasites |
JP5241100B2 (ja) * | 2006-12-28 | 2013-07-17 | シスメックス株式会社 | 抗原賦活化液、抗原賦活化方法及び細胞の検出方法 |
US9683256B2 (en) | 2007-10-01 | 2017-06-20 | Longhorn Vaccines And Diagnostics, Llc | Biological specimen collection and transport system |
US11041215B2 (en) | 2007-08-24 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | PCR ready compositions and methods for detecting and identifying nucleic acid sequences |
CA2861667C (en) * | 2007-10-01 | 2017-06-13 | Longhorn Vaccines And Diagnostics, Llc | Biological specimen collection and transport system and methods of use |
US11041216B2 (en) | 2007-10-01 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples |
CA2744987C (en) | 2008-12-02 | 2018-01-16 | Chiralgen, Ltd. | Method for the synthesis of phosphorus atom modified nucleic acids |
BR112012000828A8 (pt) | 2009-07-06 | 2017-10-10 | Ontorii Inc | Novas pró-drogas de ácido nucleico e métodos de uso das mesmas |
US10428019B2 (en) | 2010-09-24 | 2019-10-01 | Wave Life Sciences Ltd. | Chiral auxiliaries |
RU2014105311A (ru) | 2011-07-19 | 2015-08-27 | Уэйв Лайф Сайенсес Пте. Лтд. | Способы синтеза функционализованных нуклеиновых кислот |
MX356830B (es) | 2012-07-13 | 2018-06-15 | Shin Nippon Biomedical Laboratories Ltd | Adyuvante de acido nucleico quiral. |
JP6268157B2 (ja) | 2012-07-13 | 2018-01-24 | 株式会社Wave Life Sciences Japan | 不斉補助基 |
SG10201912895PA (en) | 2012-07-13 | 2020-02-27 | Wave Life Sciences Ltd | Chiral control |
WO2015108048A1 (ja) | 2014-01-15 | 2015-07-23 | 株式会社新日本科学 | 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤 |
JPWO2015108047A1 (ja) | 2014-01-15 | 2017-03-23 | 株式会社新日本科学 | 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤 |
JPWO2015108046A1 (ja) | 2014-01-15 | 2017-03-23 | 株式会社新日本科学 | 抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤 |
KR102423317B1 (ko) | 2014-01-16 | 2022-07-22 | 웨이브 라이프 사이언시스 리미티드 | 키랄 디자인 |
CN107367417B (zh) * | 2017-07-14 | 2021-06-22 | 上海市松江区中心医院 | 一种超声引导下穿刺细胞快速固定剂组合物及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5521300A (en) * | 1991-08-13 | 1996-05-28 | Norval B. Galloway | Oligonucleotides complementary to mycobacterial nucleic acids |
US5422277A (en) * | 1992-03-27 | 1995-06-06 | Ortho Diagnostic Systems Inc. | Cell fixative composition and method of staining cells without destroying the cell surface |
DE69327454T2 (de) * | 1992-10-09 | 2000-05-11 | Vysis Inc | Analytisches verfahren |
US6538107B1 (en) * | 1994-09-30 | 2003-03-25 | Takeda Chemical Industries, Ltd. | G protein coupled receptor protein production, and use thereof |
US6720355B2 (en) * | 1997-02-21 | 2004-04-13 | The Regents Of The University Of California | Sodium dodecyl sulfate compositions for inactivating prions |
US6835393B2 (en) * | 1998-01-05 | 2004-12-28 | University Of Washington | Enhanced transport using membrane disruptive agents |
US5985571A (en) * | 1998-02-04 | 1999-11-16 | Ludwig Institute For Cancer Research | Method for determining multiple myeloma by assaying for expression of mage genes |
PT1080228E (pt) | 1998-05-18 | 2010-07-22 | Igenex Inc | MéTODO DE HIBRIDAÃO IN SITU PARA A DETECÃO DE áCIDO NUCLEICO ALVO |
ATE554166T1 (de) * | 2003-07-25 | 2012-05-15 | Life Technologies Corp | Verfahren und zusammensetzungen zur herstellung von rna aus einer fixierten probe |
US7130725B2 (en) * | 2004-12-17 | 2006-10-31 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Method for correcting control surface angle measurements in single viewpoint photogrammetry |
-
2006
- 2006-07-27 DK DK06788834.7T patent/DK1924252T3/da active
- 2006-07-27 EP EP06788834A patent/EP1924252B1/en active Active
- 2006-07-27 AT AT06788834T patent/ATE523193T1/de active
- 2006-07-27 BR BRPI0615958A patent/BRPI0615958B8/pt active IP Right Grant
- 2006-07-27 ES ES06788834T patent/ES2372538T3/es active Active
- 2006-07-27 JP JP2008524212A patent/JP5132557B2/ja active Active
- 2006-07-27 PT PT06788834T patent/PT1924252E/pt unknown
- 2006-07-27 PL PL06788834T patent/PL1924252T3/pl unknown
- 2006-07-27 SI SI200631111T patent/SI1924252T1/sl unknown
- 2006-07-27 WO PCT/US2006/029501 patent/WO2007016379A2/en active Application Filing
- 2006-07-27 US US11/494,430 patent/US8632963B2/en active Active
- 2006-07-27 CA CA2641599A patent/CA2641599C/en active Active
- 2006-07-27 ZA ZA200801859A patent/ZA200801859B/xx unknown
- 2006-07-27 AU AU2006275632A patent/AU2006275632B2/en not_active Ceased
- 2006-07-27 CN CNA2006800352767A patent/CN101272773A/zh active Pending
-
2011
- 2011-10-25 CY CY20111101010T patent/CY1111959T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU2006275632A1 (en) | 2007-02-08 |
PL1924252T3 (pl) | 2012-02-29 |
AU2006275632B2 (en) | 2011-11-03 |
PT1924252E (pt) | 2011-12-16 |
CY1111959T1 (el) | 2015-11-04 |
BRPI0615958B1 (pt) | 2020-11-10 |
US8632963B2 (en) | 2014-01-21 |
JP5132557B2 (ja) | 2013-01-30 |
DK1924252T3 (da) | 2011-11-14 |
EP1924252B1 (en) | 2011-09-07 |
ZA200801859B (en) | 2009-07-29 |
WO2007016379A2 (en) | 2007-02-08 |
CN101272773A (zh) | 2008-09-24 |
ATE523193T1 (de) | 2011-09-15 |
BRPI0615958A2 (pt) | 2011-05-31 |
CA2641599A1 (en) | 2007-02-08 |
ES2372538T3 (es) | 2012-01-23 |
CA2641599C (en) | 2012-07-10 |
EP1924252A2 (en) | 2008-05-28 |
JP2009502177A (ja) | 2009-01-29 |
EP1924252A4 (en) | 2010-03-17 |
SI1924252T1 (sl) | 2011-12-30 |
WO2007016379A3 (en) | 2007-07-12 |
US20070042358A1 (en) | 2007-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0615958B8 (pt) | composição para aumentar a permeabilidade de paredes celulares e membranas celulares de mycobacterium sp. e método para detectar um alvo em uma célula | |
Gutarowska et al. | Metabolomic and high-throughput sequencing analysis—modern approach for the assessment of biodeterioration of materials from historic buildings | |
EA201101581A1 (ru) | Улучшенный способ культивирования клеток | |
WO2004076683A3 (en) | Random array dna analysis by hybridization | |
DE60210621D1 (de) | Universelle methode und zusammensetzung zur schnellen lysierung von zellen zur freisetzung von nukleinsäuren und ihre detektion | |
WO2010083250A3 (en) | Single-cell nucleic acid analysis | |
EP1994142A4 (en) | METHODS AND COMPOSITIONS FOR RAPID ISOLATION OF SMALL RNA MOLECULES | |
MX2009004043A (es) | Incorporacion genetica de aminoacidos no naturales a proteinas en celulas mamiferas. | |
EP2641911A3 (en) | Compositions and methods for re-programming cells without genetic modification | |
WO2007092916A3 (en) | Methods of extracting rna | |
WO2007098379A3 (en) | Methods of extracting nucleic acids | |
Nuccio et al. | HT-SIP: a semi-automated stable isotope probing pipeline identifies cross-kingdom interactions in the hyphosphere of arbuscular mycorrhizal fungi | |
ATE452187T1 (de) | Methode zur isolation von nukleinsäuren | |
NZ613671A (en) | Improved methods for determining cell viability using molecular nucleic acid-based techniques | |
GB0503172D0 (en) | Detection method | |
CA2639414A1 (en) | Membrane concentration assay with nucleic acid cleavage for measuring a component of whole blood | |
WO2005079531A3 (en) | Method and system for eluting cells | |
Probst et al. | Are we there yet? Understanding interplanetary microbial hitchhikers using molecular methods | |
WO2010039189A3 (en) | Methods for sequencing degraded or modified nucleic acids | |
WO2021096466A3 (en) | Apparatus and usage methods for early warning and real time diagnosis of biological agents in air | |
WO2008049583A3 (de) | Verfahren zur selektiven lokalisierung von wirkstoffen an und in mitochondrien und entsprechende wirkstoffe | |
Hanna et al. | Free and membrane-bound ribosomes: I. Separation by two-dimensional gel electrophoresis of proteins from rat liver monosomes | |
Lech et al. | Evaluation of a modified sampling method for molecular analysis of air microflora | |
Kolecka et al. | Biofilm formation and adhesive/invasive properties of Candida dubliniensis in comparison with Candida albicans | |
Ishibashi | Virus-induced metabolic rewiring of a marine algal glycosphingolipid biosynthesis pathway during infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/11/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/07/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |